​

Boston Scientific (BSX) Stock Forecast, Price Target & Predictions

OverviewRevenueOwnershipFinancialsChartTranscripts

BSX Stock Forecast

Boston Scientific (BSX) stock forecast, based on 44 Wall Street analysts, predicts a 12-month average price target of $65.20, with a high of $100.00 and a low of $48.00. This represents a 50.82% increase from the last price of $43.23.

$35 $48 $61 $74 $87 $100 High: $100 Avg: $65.2 Low: $48 Last Closed Price: $43.23

BSX Stock Rating

Boston Scientific stock's rating consensus is Buy, based on 44 Wall Street analysts. The breakdown includes 1 Strong Buy (2.27%), 36 Buy (81.82%), 7 Hold (15.91%), 0 Sell (0.00%), and 0 Strong Sell (0.00%).

Buy
Total 44 7 36 1 Strong Sell Sell Hold Buy Strong Buy

BSX Price Target Upside V Benchmarks

TypeNameUpside
StockBoston Scientific50.82%
SectorHealthcare Stocks 15.45%
IndustryMedical Device Stocks25.96%

Price Target Trends

1M3M12M
# Anlaysts32075
Avg Price Target$56.33$63.65$87.64
Last Closing Price$43.23$43.23$43.23
Upside/Downside30.30%47.24%102.73%
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Oct, 268176--31
Sep, 268185--31
Aug, 268194--31
Jul, 267194--30
Jun, 267204--31
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Sep 23, 2026Larry BiegelsenWells Fargo$48.00$44.627.58%11.03%
Sep 21, 2026Suraj KaliaOppenheimer$65.00$43.3449.98%50.36%
Sep 09, 2026Marie ThibaultBTIG$56.00$44.9824.50%29.54%
Jul 30, 2026Shagun SinghRBC Capital$70.00$44.8056.25%61.92%
Jul 30, 2026UBS$67.00$44.9049.22%54.98%
Jul 30, 2026Pito ChickeringDeutsche Bank$60.00$44.9333.54%38.79%
Jul 30, 2026Robert W. Baird$56.00$46.0421.63%29.54%
Jul 30, 2026Canaccord Genuity$66.00$46.0443.35%52.67%
Jul 30, 2026Wells Fargo$50.00$46.048.60%15.66%
Jul 30, 2026Leerink Partners$60.00$46.0430.32%38.79%
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
Sep 21, 2026OppenheimerOutperformOutperformhold
Sep 17, 2026Cowen & Co.BuyBuyhold
Sep 17, 2026CitigroupBuyNeutraldowngrade
Sep 09, 2026BTIGBuyBuyhold
Aug 25, 2026Cowen & Co.BuyBuyhold
Jul 31, 2026Raymond JamesOutperformOutperformdowngrade
Jul 30, 2026Deutsche BankBuyBuyhold
Jul 30, 2026CitigroupBuyBuyhold
Jul 30, 2026Raymond JamesOutperformOutperformhold
Jul 29, 2026BTIGBuyBuyhold

Financial Forecast

EPS Forecast

$0 $1 $2 $3 $4 $5 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$0.69$0.45$1.08$1.26$1.96---
Avg Forecast$1.61$1.73$2.01$2.47$2.81$3.20$3.56$3.96
High Forecast$1.65$1.78$2.02$2.48$2.86$3.93$4.46$4.08
Low Forecast$1.59$1.68$2.00$2.46$2.76$2.46$2.61$3.80
Surprise %-57.14%-73.99%-46.27%-48.99%-30.25%---

Revenue Forecast

$10B $14B $18B $22B $26B $30B Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$11.89B$12.68B$14.24B$16.75B$20.07B---
Avg Forecast$11.87B$12.68B$14.12B$16.61B$18.79B$20.70B$22.61B$24.63B
High Forecast$12.08B$12.97B$14.13B$16.68B$19.18B$20.70B$22.67B$25.22B
Low Forecast$11.73B$12.36B$14.08B$16.54B$18.30B$20.70B$22.54B$23.83B
Surprise %0.12%-0.02%0.88%0.83%6.83%---

Net Income Forecast

$500M $2B $3B $4B $6B $7B Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$1.04B$698.00M$1.59B$1.85B$2.89B---
Avg Forecast$947.28M$909.12M$1.57B$3.61B$4.11B$4.68B$3.93B$5.80B
High Forecast$1.14B$1.09B$1.88B$3.62B$4.19B$5.76B$6.52B$5.98B
Low Forecast$757.83M$727.30M$1.26B$3.59B$4.04B$3.60B$3.81B$5.55B
Surprise %9.79%-23.22%1.46%-48.62%-29.84%---

BSX Forecast FAQ

Is Boston Scientific stock a buy?

Boston Scientific stock has a consensus rating of Buy, based on 44 Wall Street analysts. The rating breakdown includes 1 Strong Buy, 36 Buy, 7 Hold, 0 Sell, and 0 Strong Sell, reflecting a consensus that Boston Scientific is a favorable investment for most analysts.

What is Boston Scientific's price target?

Boston Scientific's price target, set by 44 Wall Street analysts, averages $65.2 over the next 12 months. The price target range spans from $48 at the low end to $100 at the high end, suggesting a potential 50.82% change from the previous closing price of $43.23.

How does Boston Scientific stock forecast compare to its benchmarks?

Boston Scientific's stock forecast shows a 50.82% upside, outperforming the average forecast for the healthcare stocks sector (15.45%) and outperforming the medical device stocks industry (25.96%).

What is the breakdown of analyst ratings for Boston Scientific over the past three months?

  • October 2026: 25.81% Strong Buy, 54.84% Buy, 19.35% Hold, 0% Sell, 0% Strong Sell.
  • September 2026: 25.81% Strong Buy, 58.06% Buy, 16.13% Hold, 0% Sell, 0% Strong Sell.
  • August 2026: 25.81% Strong Buy, 61.29% Buy, 12.90% Hold, 0% Sell, 0% Strong Sell.

What is Boston Scientific’s EPS forecast?

Boston Scientific's average annual EPS forecast for its fiscal year ending in December 2026 is $3.2, marking a 63.27% increase from the reported $1.96 in 2025. Estimates for the following years are $3.56 in 2027, and $3.96 in 2028.

What is Boston Scientific’s revenue forecast?

Boston Scientific's average annual revenue forecast for its fiscal year ending in December 2026 is $20.7B, reflecting a 3.10% increase from the reported $20.07B in 2025. The forecast for 2027 is $22.61B, and $24.63B for 2028.

What is Boston Scientific’s net income forecast?

Boston Scientific's net income forecast for the fiscal year ending in December 2026 stands at $4.68B, representing an 62.16% increase from the reported $2.89B in 2025. Projections indicate $3.93B in 2027, and $5.8B in 2028.